Quantitative measurement of total erbB2 (H2T), p110 t-erbB2, and erbB2: erbB3 (H23D) heterodimer expression and p110 t-erbB2 in malignant progression from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC)-MedSci.cn

Quantitative measurement of total erbB2 (H2T), p110 t-erbB2, and erbB2: erbB3 (H23D) heterodimer expression and p110 t-erbB2 in malignant progression from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC)

Zong, Y; Shen, KW; Sperinde, J; Wallweber, G; Huang, WD; Winslow, JW

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):

科室
- - 订阅+
  - 更多科室
工具
服务